EUVIMEDEUVIMED entdecken
Open Access

Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2

Guixing Jiang, Yunfu Cui, Xin Yu, Zhengrong Wu, Guoping Ding, Liping Cao

Oncotarget · 06.01.2026 · 17 (1) · 199-200

DOI: 10.18632/oncotarget.28837 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, erschienen am 06.01.2026. Verfasst von Guixing Jiang und 5 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Jiang, G., Cui, Y., Yu, X., Wu, Z., Ding, G., & Cao, L. (2026). Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2. Oncotarget, 17(1), 199-200. https://doi.org/10.18632/oncotarget.28837

Vancouver

Jiang G, Cui Y, Yu X, Wu Z, Ding G, Cao L. Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2. Oncotarget. 2026;17(1):199-200. doi:10.18632/oncotarget.28837

BibTeX
@article{Jiang2026,
  author = {Jiang, Guixing and Cui, Yunfu and Yu, Xin and Wu, Zhengrong and Ding, Guoping and Cao, Liping},
  title = {Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2},
  journal = {Oncotarget},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {199--200},
  doi = {10.18632/oncotarget.28837}
}
Kostenlos starten →